2021 – Page 10 – Policy & Medicine

Legislation Introduced to Require Controlled Substance Providers Complete Continuing Education

FDA Releases Draft Guidance on Sponsor Safety Reporting Requirements

Government Intervenes in False Claims Act Suit Against Kaiser

Xavier Becerra Supports Continued Use of Telehealth

Interim Final Rule Released on Surprise Billing and Out-of-Network Charges

Pfizer Agrees to Pay $345 Million to Resolve EpiPen Anti-Competitive Allegations

Most Hospitals Not Abiding by Transparency Rule

Congress to Investigate Aduhelm Approval

August 2021 Issue P&M Compliance Update features interview with Creator of California AB-1278 Open Payments Transparency Bill

Discussion Draft for Cures 2.0 Starts Making the Rounds